These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2831669)

  • 1. Inactivation of lipid-enveloped viruses in labile blood derivatives by unsaturated fatty acids.
    Horowitz B; Piët MP; Prince AM; Edwards CA; Lippin A; Walakovits LA
    Vox Sang; 1988; 54(1):14-20. PubMed ID: 2831669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral safety of solvent-detergent treated blood products.
    Horowitz B; Prince AM; Horowitz MS; Watklevicz C
    Dev Biol Stand; 1993; 81():147-61. PubMed ID: 8174797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine-mediated inactivation of lipid- and nonlipid-enveloped viruses in human antithrombin III concentrate.
    Highsmith F; Xue H; Chen X; Benade L; Owens J; Shanbrom E; Drohan W
    Blood; 1995 Jul; 86(2):791-6. PubMed ID: 7606009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tri(n-butyl) phosphate/detergent treatment of licensed therapeutic and experimental blood derivatives.
    Edwards CA; Piet MP; Chin S; Horowitz B
    Vox Sang; 1987; 52(1-2):53-9. PubMed ID: 3111089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of viruses in blood with aluminum phthalocyanine derivatives.
    Horowitz B; Williams B; Rywkin S; Prince AM; Pascual D; Geacintov N; Valinsky J
    Transfusion; 1991 Feb; 31(2):102-8. PubMed ID: 1847558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unsaturated free fatty acids inactivate animal enveloped viruses.
    Kohn A; Gitelman J; Inbar M
    Arch Virol; 1980; 66(4):301-7. PubMed ID: 7447706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of tri(n-butyl)phosphate detergent mixtures to inactivate hepatitis viruses and human immunodeficiency virus in plasma and plasma's subsequent fractionation.
    Piët MP; Chin S; Prince AM; Brotman B; Cundell AM; Horowitz B
    Transfusion; 1990 Sep; 30(7):591-8. PubMed ID: 2402772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virucidal short wavelength ultraviolet light treatment of plasma and factor VIII concentrate: protection of proteins by antioxidants.
    Chin S; Williams B; Gottlieb P; Margolis-Nunno H; Ben-Hur E; Hamman J; Jin R; Dubovi E; Horowitz B
    Blood; 1995 Dec; 86(11):4331-6. PubMed ID: 7492794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of lipid enveloped viruses by octanoic Acid treatment of immunoglobulin solution.
    Dichtelmüller H; Rudnick D; Kloft M
    Biologicals; 2002 Jun; 30(2):135-42. PubMed ID: 12127315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate.
    Krebs FC; Miller SR; Malamud D; Howett MK; Wigdahl B
    Antiviral Res; 1999 Oct; 43(3):157-73. PubMed ID: 10551374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma.
    Horowitz B; Bonomo R; Prince AM; Chin SN; Brotman B; Shulman RW
    Blood; 1992 Feb; 79(3):826-31. PubMed ID: 1310064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of viruses in labile blood derivatives. II. Physical methods.
    Horowitz B; Wiebe ME; Lippin A; Vandersande J; Stryker MH
    Transfusion; 1985; 25(6):523-7. PubMed ID: 3934802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides.
    Thormar H; Isaacs CE; Brown HR; Barshatzky MR; Pessolano T
    Antimicrob Agents Chemother; 1987 Jan; 31(1):27-31. PubMed ID: 3032090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low pH, caprylate incubation as a second viral inactivation step in the manufacture of albumin. Parametric and validation studies.
    Johnston A; Uren E; Johnstone D; Wu J
    Biologicals; 2003 Sep; 31(3):213-21. PubMed ID: 12935811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma.
    Kim IS; Choi YW; Kang Y; Sung HM; Shin JS
    J Microbiol Biotechnol; 2008 May; 18(5):997-1003. PubMed ID: 18633304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and physical properties of a solvent-detergent-treated fibrin glue.
    Burnouf-Radosevich M; Burnouf T; Huart JJ
    Vox Sang; 1990; 58(2):77-84. PubMed ID: 2160146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photochemical decontamination of red blood cell concentrates with the silicon phthalocyanine PC 4 and red light.
    Ben-Hur E; Chan WS; Yim Z; Zuk MM; Dayal V; Roth N; Heldman E; Lazo A; Valeri CR; Horowitz B
    Dev Biol (Basel); 2000; 102():149-55. PubMed ID: 10794102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inactivation of viruses which can potentially contaminate blood products.
    Horowitz B
    Dev Biol Stand; 1991; 75():43-52. PubMed ID: 1794631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of viruses in labile blood derivatives. I. Disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations.
    Horowitz B; Wiebe ME; Lippin A; Stryker MH
    Transfusion; 1985; 25(6):516-22. PubMed ID: 3934801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral inactivation of vesicular stomatitis virus in normal human serum by cross-linked polyvinylpyrrolidone.
    Highsmith FA; Caple M; Walthall B; Shanbrom E; Drohan WN
    J Infect Dis; 1993 May; 167(5):1027-33. PubMed ID: 8387559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.